Peter M. Neupert is Director at LABORATORY CORP OF AMERICA HOLDINGS (LH). They have made 5 open-market trades across 3 companies since 2022, most recently 2026-08-17.
CIK 0001237566
3 open-market purchases totalling $1.9M since 2022, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FTRE | 246,668 | $5.6M |
| LH | 13,784 | $4.4M |
| ADPT | 130,625 | $3.1M |
| QSII | 5,836 | $130K |
| Total | $13.2M |
Shares reported on the most recent Form 4, priced at the 2026-08-19 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADPT | SELL | 2026-08-17 | 2026-08-19 | $25.15 | $3.1M | -1.7% | +13.0% | — |
| FTRE | BUY | 2025-08-08 | 2025-08-11 | $6.51 | $407K | +12.4% | +45.3% | +62.3% |
| ADPT | SELL | 2025-03-10 | 2025-03-12 | $7.05 | $71K | +15.5% | +5.9% | +39.5% |
| FTRE | BUY | 2023-08-23 | 2023-08-23 | $25.30 | $278K | -1.7% | +3.8% | +21.9% |
| LH | BUY | 2022-02-16 | 2022-02-18 | $263.44 | $1.3M | +2.2% | +4.6% | -6.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.